The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Phosphorylation Meets Ubiquitination: The Control of NF-κB Activity
Abstract
NF-kappaB (nuclear factor-kappaB) is a collective name for inducible dimeric transcription factors composed of members of the Rel family of DNA-binding proteins that recognize a common sequence motif. NF-kappaB is found in essentially all cell types and is involved in activation of an exceptionally large number of genes in response to infections, inflammation, and other stressful situations requiring rapid reprogramming of gene expression. NF-kappaB is normally sequestered in the cytoplasm of nonstimulated cells and consequently must be translocated into the nucleus to function. The subcellular location of NF-kappaB is controlled by a family of inhibitory proteins, IkappaBs, which bind NF-kappaB and mask its nuclear localization signal, thereby preventing nuclear uptake. Exposure of cells to a variety of extracellular stimuli leads to the rapid phosphorylation, ubiquitination, and ultimately proteolytic degradation of IkappaB, which frees NF-kappaB to translocate to the nucleus where it regulates gene transcription. NF-kappaB activation represents a paradigm for controlling the function of a regulatory protein via ubiquitination-dependent proteolysis, as an integral part of a phosphorylationbased signaling cascade. Recently, considerable progress has been made in understanding the details of the signaling pathways that regulate NF-kappaB activity, particularly those responding to the proinflammatory cytokines tumor necrosis factor-alpha and interleukin-1. The multisubunit Ika…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Because of its ability to regulate the expression of inflammatory proteins, NFκB is believed to play a major role in the inflammatory process.”
From Thymosin beta 4 suppression of corneal NFκB: A potential anti-inflammatory pathway (2007) · cites this paper as Karin and Ben-Neriah, 2000
In the citing paper
“NFκB-induced gene expression requires that NFκB not only becomes activated, but it must also be phosphorylated and must physically translocate from cytoplasm to the nucleus (Karin and Ben-Neriah, 2000).”
From Thymosin beta 4 suppression of corneal NFκB: A potential anti-inflammatory pathway (2007) · cites this paper as Karin and Ben-Neriah, 2000
Citations
Cites
Function and Activation of NF-kappaB in the Immune System
Baeuerle, P. A., & Henkel, T. (1994) · Annual Review of Immunology · doi:10.1146/annurev.iy.12.040194.001041 · Cited by 4,745
The N-end rule: functions, mysteries, uses
Varshavsky, A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.22.12142 · Cited by 859
A CONSERVED SIGNALING PATHWAY: The Drosophila Toll-Dorsal Pathway
Belvin, M. P., & Anderson, K. V. (1996) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.12.1.393 · Cited by 836
A common human skin tumour is caused by activating mutations in β-catenin
Chan, E., Gat, U., McNiff, J. M., & Fuchs, E. (1999) · Nature Genetics · doi:10.1038/7747 · Cited by 612
A novel ionizing radiation-induced signaling pathway that activates the transcription factor NF-κB
Lee, S.-J., Dimtchev, A., Lavin, M. F., Dritschilo, A., & Jung, M. (1998) · Oncogene · doi:10.1038/sj.onc.1202088 · Cited by 136
Research works printed but not linked: 229
- 10.1016/0092-8674(86)90807-X · DOI
- Baldwin AS. 1996. The NF-κB and IκB proteins: new discoveries and insights. Annu. Rev. Immunol. 14:649–81 · DOI
- Ghosh S, May MJ, Kopp EB. 1998. NFκB and Rel proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 16:225–60 · DOI
- 10.1016/S0065-230X(08)60257-2 · DOI
- 10.1146/annurev.cb.10.110194.002201 · DOI
- 10.1006/scbi.1997.0060 · DOI
- Whiteside ST, Israël A. 1997. I κ B proteins: structure, function and regulation. Semin. Cancer Biol. 8:75–82 · DOI
- 1997, J. Cell Sci., 110, 369, 10.1242/jcs.110.3.369 · DOI
- 10.1128/MCB.16.5.2341 · DOI
- 10.1101/gad.9.22.2736 · DOI
- 10.1084/jem.188.6.1055 · DOI
- 10.1038/34356 · DOI
- 10.1038/nsb0198-67 · DOI
- 10.1038/373303a0 · DOI
- 10.1038/373311a0 · DOI
- 10.1016/S0092-8674(00)81699-2 · DOI
- 10.1016/S0092-8674(00)81698-0 · DOI
- 10.1016/S0065-2776(08)60742-7 · DOI
- 10.1056/NEJM199704103361506 · DOI
- 10.1146/annurev.biochem.67.1.227 · DOI · Paper page
- 10.1146/annurev.immunol.15.1.749 · DOI · Paper page
- 1995, Microbiol. Rev., 59, 481, 10.1128/mr.59.3.481-505.1995 · DOI
- 10.1006/meth.1998.0646 · DOI
- Baichwal VR, Baeuerle PA. 1997. Activate NF-κB or die? Curr. Biol. 7:R94–96 · DOI
- 10.1006/scbi.1997.0062 · DOI
- 1996, Oncogene, 13, 1367
- 10.1006/scbi.1997.0061 · DOI
- Grilli M, Memo M. 1999. NF-κB/Rel proteins: a point of convergence of signalling pathways relevant in neuronal function and dysfunction. Biochem. Pharmacol. 57:1–7 · DOI
- 10.1073/pnas.95.14.8211 · DOI
- 10.1183/09031936.98.12010221 · DOI
- 10.1136/gut.43.6.856 · DOI
- 10.1128/MCB.15.5.2809 · DOI
- 10.1126/science.7878466 · DOI · Paper page
- 10.1128/MCB.15.3.1302 · DOI · Paper page
- 10.1128/MCB.16.4.1295 · DOI · Paper page
- 10.1002/j.1460-2075.1995.tb07287.x · DOI
- 10.1128/MCB.15.10.5339 · DOI
- 10.1038/25159 · DOI
- 10.1016/S0092-8674(00)80752-7 · DOI
- 10.1101/gad.13.5.505 · DOI
- 10.1101/gad.9.13.1586 · DOI
- 10.1073/pnas.92.24.11259 · DOI
- 10.1074/jbc.271.1.376 · DOI
- 10.1073/pnas.92.23.10599 · DOI
- Lin Y-C, Brown K, Siebenlist U. 1995. Activation of NF-κB requires proteolysis of the inhibitor IκB: Signal-induced phosphorylation of IκB alone does not release active NF-κB. Proc. Natl. Acad. Sci. USA 92:3003–9 · DOI
- 10.1016/S0092-8674(00)80153-1 · DOI
- 10.1073/pnas.96.2.429 · DOI
- 10.1093/emboj/17.17.5170 · DOI
- 10.1073/pnas.95.22.13012 · DOI
- 10.1038/41493 · DOI · Paper page
- Mercurio F, Zhu H, Murray BW, Shevchenko A, Bennett BL, Li J, Young DB, Barbosa M, Mann M, Manning A, Rao A. 1997. IKK-1 and IKK-2: cytokineactivated IκB kinases essential for NFκB activation. Science 278:860–66 · DOI
- 10.1016/S0092-8674(00)81064-8 · DOI
- 10.1016/S0092-8674(00)81842-5 · DOI
- 10.1016/S0092-8674(00)80406-7 · DOI
- 10.1016/S0092-8674(00)80344-X · DOI
- 10.1126/science.278.5339.866 · DOI
- 1995, Cell. Mol. Biol. Res., 41, 537
- 10.1038/26261 · DOI
- 10.1016/S0092-8674(00)81466-X · DOI
- 10.1128/MCB.19.2.1526 · DOI
- 10.1073/pnas.96.3.1042 · DOI
- 1990, J. Immunol., 145, 3080, 10.4049/jimmunol.145.9.3080 · DOI
- 10.1038/26254 · DOI
- 10.1046/j.1432-1327.1999.00028.x · DOI
- 10.1016/S1097-2765(00)80179-3 · DOI
- Zandi E, Chen Y, Karin M. 1998. Direct phosphorylation of IκB by IKKα and IKKβ: discrimination between free and NF-κB-bound substrate. Science 281:1360–63 · DOI
- 10.1126/science.284.5412.321 · DOI
- 10.1084/jem.189.11.1839 · DOI
- 10.1016/S1074-7613(00)80042-4 · DOI
- 10.1074/jbc.274.22.15297 · DOI
- 10.1074/jbc.273.20.12041 · DOI
- 10.1074/jbc.273.46.30736 · DOI
- 10.1073/pnas.95.7.3792 · DOI
- 10.1126/science.284.5412.309 · DOI
- 10.1016/S0092-8674(00)81092-2 · DOI
- 10.1128/MCB.19.3.2180 · DOI
- 10.1128/MCB.18.10.5899 · DOI
- 10.1038/43474 · DOI · Paper page
- 10.1038/43466 · DOI · Paper page
- 10.1128/MCB.18.12.7336 · DOI
- 10.1073/pnas.95.16.9319 · DOI
- 10.1128/MCB.19.1.21 · DOI
- 10.1023/A:1021925629248 · DOI
- 10.1038/18465 · DOI
- 10.1074/jbc.274.15.10641 · DOI
- 10.1038/385540a0 · DOI
- Song HY, Régnier CH, Kirschning CJ, Goeddel DV, Rothe M. 1997. Tumor necrosis factor (TNF)-mediated kinase cascades: bifurcation of nuclear factorκB and c-jun N-terminal kinase (JNK/ SAPK) pathways at TNF receptor-associated factor 2. Proc. Natl. Acad. Sci. USA 94:9792–96 · DOI
- Baud V, Liu Z-G, Bennett B, Suzuki N, Xia Y, Karin M. 1999. Signaling by proinflammatory cytokines: oligomerization of TRAF2 and TRAF6 is sufficient for JNK and IKK activation and target gene induction via an N-terminal effector domain. Genes Dev. 13:1297– 308 · DOI
- 10.1126/science.284.5412.316 · DOI
- 10.1126/science.284.5412.313 · DOI
- 10.1038/8780 · DOI
- 10.1093/intimm/8.1.23 · DOI
- 10.1101/gad.12.21.3369 · DOI
- 10.1016/S1074-7613(00)80390-8 · DOI
- 10.1016/S1074-7613(00)80391-X · DOI
- 10.1073/pnas.95.5.2307 · DOI
- 10.1146/annurev.ge.29.120195.002103 · DOI
- 10.1101/gad.5.10.1892 · DOI
- 10.1016/0092-8674(91)90014-P · DOI
- 10.1038/ng0197-42 · DOI
- 10.1038/ng0197-36 · DOI
- 10.1038/376167a0 · DOI
- 10.1016/S1074-7613(00)80451-3 · DOI
- 10.1073/pnas.96.6.2994 · DOI
- Vandenabeele P, Declercg W, Beyaert R, Fiers W. 1995. Two tumour necrosis factor receptors: structure and function. Trends Cell. Biol. 5:392–99 · DOI · Paper page
- 10.1038/sj.onc.1202568 · DOI
- 10.1016/S0898-6568(98)00018-7 · DOI
- 10.1073/pnas.90.13.6155 · DOI
- Auron PE. 1998. The interleukin 1 receptor: ligand interactions and signal transduction. Cytokine Growth Factor Rev. 9:221–37 · DOI
- 10.1016/S1074-7613(00)80535-X · DOI · Paper page
- 10.1074/jbc.270.23.13757 · DOI
- Wesche H, Henzel WJ, Shillinglaw W, Li S, Cao Z. 1997. MyD88: an adapter that recruits IRAK to the IL-1 receptor complex. Immunity 7:837–47 · DOI
- Cao Z, Henzel WJ, Gao X. 1996. IRAK: a kinase associated with the interleukin1 receptor. Science 271:1128–31 · DOI
- 10.1126/science.278.5343.1612 · DOI
- 10.1038/383443a0 · DOI
- 10.1101/gad.12.18.2821 · DOI
- 10.1016/S1359-6101(98)00023-9 · DOI
- 10.1038/19110 · DOI
- 10.1126/science.7544915 · DOI
- Liu Z-G, Hu H, Goeddel DV, Karin M. 1996. Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis, while NF-κB activation prevents cell death. Cell 87:565– 76 · DOI · Paper page
- Takeuchi M, Rothe M, Goeddel DV. 1996. Anatomy of TRAF2: distinct domains for nuclear factor-κB activation and association with tumor necrosis factor signaling proteins. J. Biol. Chem. 16:19935–42 · DOI
- 10.1074/jbc.271.25.14661 · DOI
- 10.1101/gad.13.8.1015 · DOI
- 10.1074/jbc.273.35.22681 · DOI
- 10.1074/jbc.272.51.32102 · DOI
- 10.1126/science.275.5296.90 · DOI
- 10.1016/S1097-2765(00)80283-X · DOI
- 10.1016/S0959-437X(96)80062-1 · DOI
- 10.1006/scbi.1997.0059 · DOI
- 10.1006/dbio.1996.0308 · DOI
- 10.1038/35154 · DOI · Paper page
- 10.1016/S0014-5793(99)00322-1 · DOI
- 10.1042/0264-6021:3390227 · DOI
- 10.1016/S0952-7915(99)80003-X · DOI
- 10.1126/science.284.5418.1313 · DOI
- 10.1038/32195 · DOI
- Dushay MS, Asling B, Hultmark D. 1996. Origins of immunity: Relish, a compound Rel-like gene in the antibacterial defense of Drosophila. Proc. Natl. Acad. Sci. USA 93:10343–47 · DOI
- Baumeister W, Walz J, Zuhl F, Seemuller E. 1998. The proteasome: paradigm of a self-compartmentalizing protease. Cell 92:367–80 · DOI
- 10.1146/annurev.genet.30.1.405 · DOI
- 10.1146/annurev.biochem.67.1.425 · DOI · Paper page
- 10.1016/S0968-0004(97)01122-5 · DOI
- 10.1096/fasebj.11.14.9409544 · DOI
- 10.1016/0092-8674(93)90384-3 · DOI
- 10.1093/emboj/16.21.6325 · DOI · Paper page
- 10.1038/373081a0 · DOI
- 10.1038/10039 · DOI
- Zachariae W, Nosmyth K. 1999. Whose end is destruction: cell cycle division and the anaphase promoting complex. Genes Dev. 13:2039–58 · DOI
- Yamano H, Tsurumi C, Gannon J, Hunt T. 1998. The role of the destruction box and its neighbouring lysine residues in cyclin B for anaphase ubiquitin-dependent proteolysis in fission yeast: defining the D-box receptor. EMBO J. 17:5670– 78 · DOI
- 10.1016/S1097-2765(00)80126-4 · DOI
- 10.1016/S1097-2765(00)80286-5 · DOI
- Peters JM. 1998. SCF and APC: the yin and yang of cell cycle regulated proteolysis. Curr. Opin. Cell. Biol. 10:759–68 · DOI
- Patton EE, Willems AR, Tyers M. 1998. Combinatorial control in ubiquitindependent proteolysis: Don't Skp the Fbox hypothesis. Trends Genet. 14:236– 43 · DOI
- 10.1101/gad.13.12.1614 · DOI
- 10.1016/S1097-2765(00)80482-7 · DOI
- 10.1126/science.284.5414.657 · DOI
- 10.1038/20459 · DOI · Paper page
- 10.1128/MCB.18.2.732 · DOI
- 10.1126/science.284.5414.662 · DOI
- 10.1128/MCB.16.3.1058 · DOI
- 10.1093/emboj/16.21.6486 · DOI
- 10.1101/gad.7.7a.1266 · DOI
- 10.1002/j.1460-2075.1993.tb06157.x · DOI
- 10.1093/emboj/16.13.3797 · DOI
- 10.1126/science.275.5307.1790 · DOI
- 10.1126/science.275.5307.1787 · DOI
- 1998, Cancer Res., 58, 1344
- 10.1002/(SICI)1098-2264(199805)22:1<37::AID-GCC5>3.3.CO;2-P · DOI
- 1998, Cancer Res., 58, 2524
- 1998, Cancer Res., 58, 896
- 1998, Cancer Res., 58, 2520
- 1998, Cancer Res., 58, 1130
- 10.1073/pnas.95.15.8847 · DOI
- Spevak W, Keiper BD, Stratowa C, Castanon MJ. 1993. Saccharomyces cerevisiae cdc15 mutants arrested at a late stage in anaphase are rescued by Xenopus cDNAs encoding N-ras or a protein with beta-transducin repeats. Mol. Cell. Biol. 13:4953–66. Erratum. 1993. 13(11):7199 · DOI
- 10.1016/S1097-2765(00)80056-8 · DOI
- 10.1006/bbrc.1999.0289 · DOI
- 10.1073/pnas.96.7.3859 · DOI
- 10.1074/jbc.274.12.7941 · DOI
- 10.1101/gad.13.3.284 · DOI
- 10.1101/gad.13.21.2751 · DOI
- 10.1038/sj.onc.1202760 · DOI
- 10.1016/S0092-8674(00)81376-8 · DOI
- 1996, Nature, 379, 847
- 10.1038/360597a0 · DOI
- 10.1006/geno.1999.5792 · DOI
- 10.1016/S0960-9822(99)80091-8 · DOI
- 10.1093/emboj/18.9.2401 · DOI
- 10.1038/sj.onc.1202653 · DOI
- 10.1073/pnas.96.11.6273 · DOI
- 10.1016/S0925-4773(98)00134-8 · DOI
- 10.1016/S0304-419X(97)00008-5 · DOI
- 10.1016/S0165-4608(97)00479-2 · DOI
- 10.1002/(SICI)1098-2264(199808)22:4<295::AID-GCC5>3.3.CO;2-R · DOI
- 10.1038/sj.onc.1202073 · DOI
- 10.1126/science.274.5288.782 · DOI · Paper page
- Wang C-Y, Mayo MW, Baldwin AS Jr. 1996. TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-κB. Science 274:784–87 · DOI
- 10.1016/S0092-8674(00)81409-9 · DOI
- 10.1038/354395a0 · DOI
- 10.1016/S0092-8674(94)90482-0 · DOI
- Orian A, Whiteside S, Israël A, Stancovski I, Schwartz AL, Ciechanover A. 1995. Ubiquitin-mediated processing of NF-κB transcriptional activator precursor p105: reconstitution of a cell-free system and identification of the ubiquitin-carrier protein, E2, and a novel ubiquitin-protein ligase, E3, involved in conjugation. J. Biol. Chem. 270:21707– 14 · DOI
- 10.1074/jbc.273.15.8820 · DOI
200 of 229 shown
Cited by
Sorted by citations
Items 501–600 of 1,071
Liuweidihuang Pill Alleviates Inflammation of the Testis via AMPK/SIRT1/NF‐κB Pathway in Aging Rats
Wang, Y., Yang, Z., Yang, L., Zou, Q., Zhao, S., Hu, N., Chen, D., Cui, R.-Q., & Ma, H. (2020) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2020/2792738 · Cited by 17
Synthesis and anti‐inflammatory effects of novel emodin derivatives bearing azole moieties
Zhu, X.-K., Chen, Q., Yang, Y., Ai, X.-X., Chen, S., & Song, Y. (2019) · Archiv der Pharmazie · doi:10.1002/ardp.201900264 · Cited by 21
Type I Interferon Induced and Antagonized by Foot-and-Mouth Disease Virus
Ma, X.-X., Ma, L.-N., Chang, Q.-Y., Ma, P., Li, L.-J., Wang, Y.-Y., Ma, Z., & Cao, X. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01862 · Cited by 21
“…factor) family members and transmit signals to downstream protein kinases (inhibitor of NF-κB (IκB) kinase (IKK) family members, which are pivotal for activating the transcription factors IRF-3, IRF7, and NF-κB (Karin and Benneriah, 2000; Xu et al., 2005), thereby contributing to IFNs expression.”
BackgroundTran, T.-V., Park, S. J., Shin, E., Tran, H.-Q., Jeong, J., Jang, C., Lee, Y.-J., Nah, S., Nabeshima, T., & Kim, H.-C. (2018) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2017.11.004 · Cited by 21
Liu, S., Jia, H., Hou, S., Xin, T., Guo, X., Zhang, G., Gao, X., Li, M., Zhu, W., & Zhu, H. (2018) · Scientific Reports · doi:10.1038/s41598-018-20433-x · Cited by 23
Lian, S., Xia, Y., Ung, T. T., Khoi, P. N., Yoon, H. J., Lee, S. G., Kim, K. K., & Jung, Y. D. (2016) · Molecular Carcinogenesis · doi:10.1002/mc.22524 · Cited by 22
Shah, S. Z. A., Zhao, D., Taglialatela, G., Khan, S. H., Hussain, T. A., Dong, H., Lai, M., Zhou, X., & Yang, L. (2017) · Neurotherapeutics · doi:10.1007/s13311-016-0500-0 · Cited by 18
RetractedSun, W., Wang, H., Zhao, X., Yu, Y., Fan, Y., Wang, H., Wang, X., Lu, X., Zhang, G., Fu, S., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.104224 · Cited by 20
Ju, Z.-R., Shang, Z., Mahmud, T., Fang, J., Liu, Y.-H., Pan, Q., Lin, X.-P., & Chen, F.-E. (2023) · Journal of Natural Products · doi:10.1021/acs.jnatprod.2c01153 · Cited by 20
Zhou, Y., Qian, W., Li, X., & Wei, W.-Z. (2023) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2023/7098313 · Cited by 20
“Phosphorylation of IκB-α promotes the disaggregation of NF-κB and activates the NF-κB signaling pathway [27].”
BackgroundWang, W., Xiong, L.-M., Wu, Y., Zhou, Y.-R., Li, Y.-T., Zheng, M.-Z., Song, Z., Sun, D.-J., & Chen, L.-X. (2022) · Acta Materia Medica · doi:10.15212/amm-2022-0008 · Cited by 20
“To further assess whether 8d1 exerted an anti-inflammatory effect through the NF-κB signaling pathway, we pretreated cells with different concentrations of 8d1 before induction with LPS.”
BackgroundInfluentialEl-Sayed, S., Shahin, R., Fahmy, A., & Elshazly, S. (2021) · Life Science · doi:10.1016/j.lfs.2021.120144 · Cited by 20
Wang, Z.-J., Huang, W.-H., Ren, F.-F., Luo, L., Zhou, J., Huang, D.-M., Jiang, M., Du, H.-A., Fan, J.-Q., & Tang, L. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.655614 · Cited by 20
Xie, J.-J., Liao, S.-Y., Wang, R.-H., He, X., Fang, H.-H., Zhuang, Z.-X., Wei, D., Tian, L., Liu, Y.-J., & Niu, J. (2020) · Aquaculture · doi:10.1016/j.aquaculture.2019.734508 · Cited by 20
Hwang, D., Gu, P. S., Kim, N., Jang, Y. P., & Oh, M. S. (2017) · Environmental Toxicology · doi:10.1002/tox.22463 · Cited by 21
“NF-jB is a transcription factor that plays an essential role in immune and inflammatory responses through regulation of diverse genes that encode pro-inflammatory cytokines, adhesion molecules, chemokines, growth factors, and inducible enzymes.(32) Moreover, NFjB acts as an activated form in disease conditions, includ…”
BackgroundEmerging role of various signaling pathways in the pathogenesis and therapeutics of atherosclerosis
Prashar, Y., Ritu, R., Bais, S., & Gill, N. S. (2017) · Reviews in vascular medicine · doi:10.1016/j.rvm.2017.05.001 · Cited by 38
Frans, G., van der Werff, T. B. J., Moens, L., Gijsbers, R., Changi-Ashtiani, M., Rokni-Zadeh, H., Shahrooei, M., Wuyts, G., Meyts, I., & Bossuyt, X. (2017) · Journal of Clinical Immunology · doi:10.1007/s10875-017-0448-9 · Cited by 20
Thiamine antagonists trigger p53-dependent apoptosis in differentiated SH-SY5Y cells
Chornyy, S., IuM, P., & Chorna, N. (2017) · Scientific Reports · doi:10.1038/s41598-017-10878-x · Cited by 24
Ko, Y.-J., Ahn, G., Ham, Y., Song, S.-M., Ko, E.-Y., Cho, S.-H., Yoon, W., & Kim, K. (2017) · EXCLI journal · doi:10.17179/excli2017-596 · Cited by 26
“In unstimulated cells, NF-κB is present as a quiescent form bound to the inhibitory protein IκB in the cytosol (Karin and Ben-Neriah, 2000).”
BackgroundLv, L., Li, Q.-R., Wang, K., Zhao, J.-P., Deng, K.-J., Zhang, R., Chen, Z., Khan, I. A., Gui, C., Feng, S.-X., et al. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c00222 · Cited by 19
PDZ and LIM Domain-Encoding Genes: Their Role in Cancer Development
Jiang, X., Xu, Z., Jiang, S., Wang, H., Xiao, M., Shi, Y., & Wang, K. (2023) · Cancers · doi:10.3390/cancers15205042 · Cited by 18
“In unstimulated cells, NF-κ B is mainly located in the cytoplasm due to interactions with the NF-κ B inhibitor (IkB) [81].”
BackgroundMoghaddam, M., Vivarelli, S., Falzone, L., Libra, M., & Bonavida, B. (2023) · Exploration of Targeted Anti-tumor Therapy · doi:10.37349/etat.2023.00128 · Cited by 18
“NF-κB is found in nearly all cell types and is involved in the activation of genes in response to the body’s detection of infection, inflammation, and other stressful situations that require rapid reprogramming of gene expression [47].”
BackgroundMazhar, M., Yang, G., Mao, L., Liang, P., Tan, R., Wang, L., Xu, H., Yang, L., Ren, W., & Yang, S. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.850060 · Cited by 25
“The canonical pathway is triggered by proinflammatory cytokines such as TNFα and IL1 (Karin and Ben-Neriah, 2000) derived from astrocytes, neurons and majorly microglia/macrophages (Wang et al., 2011b).”
BackgroundInfluentialLiu, Y., Wang, Y., Qin, S., Jin, X., Jin, L., Gu, W., & Mu, Y. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.817620 · Cited by 20
“In addition, TNFRSF4 and MAP3K2 are involved in the activation of nuclear factor kappa B (NF-kB) (51).”
BackgroundSrivastava, R., & Lodhi, N. (2022) · Biomolecules · doi:10.3390/biom12030417 · Cited by 22
Todorović, V., McDonald, H. A., Hoover, P., Wetter, J. B., Marinopoulos, A. E., Woody, C. L., Miller, L. N., Finkielsztein, A., Dunstan, R. W., Paller, A. S., et al. (2022) · Experimental Dermatology · doi:10.1111/exd.14551 · Cited by 20
Xia, G.-Y., Fang, D.-J., Wang, L., Xia, H., Wang, Y.-N., Shang, H.-C., & Lin, S. (2021) · Phytochemistry · doi:10.1016/j.phytochem.2021.113023 · Cited by 19
The NF-κB Pathway: Modulation by Entamoeba histolytica and Other Protozoan Parasites
Chadha, A., & Chadee, K. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.748404 · Cited by 19
“The phosphorylation of IkB at N-terminal Ser 32 and Ser 36 (Karin and Ben-Neriah, 2000), mediated by IKK, leads to Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 3 proteasomal degradation of the inhibitory subunit by 26S proteasome, resulting in NF-kB activation.…”
BackgroundGenetic Events Inhibiting Apoptosis in Diffuse Large B Cell Lymphoma
Léveillé, E., & Johnson, N. A. (2021) · Cancers · doi:10.3390/cancers13092167 · Cited by 26
“This leads to formation of the CARD11-BCL10-MALT1 (CBM) complex, which allows translocation of cytoplasmic NF-kB to the nucleus to facilitate target gene transcription [132-134].”
BackgroundSumayya, A. S., & Kurup, G. M. (2021) · Journal of Biomaterials Science Polymer Edition · doi:10.1080/09205063.2021.1899590 · Cited by 27
Nguyen, T. H., Nachtergael, A., Nguyen, T. M., Cornet, V., Duez, P., Muller, M., Duong, H., & Kestemont, P. (2020) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2020.112739 · Cited by 19
“…from a complex with I-κB, now becoming enabled to migrate to the nucleus where it binds to the cisacting κB enhancer element of target genes and induces transcription of its target genes such as COX-2, iNOS, TNF-α, IL-1β, and IL-6, chemokines and adhesion molecules (Karin and Ben-neriah, 2000).”
BackgroundDeng, H., Hu, L., Li, J.-J., Yan, W., Song, E.-H., Kuang, M., Liu, S., He, J.-G., & Weng, S. (2019) · Developmental and Comparative Immunology · doi:10.1016/j.dci.2019.103581 · Cited by 19
Zarredar, H., Pashapour, S., Farajnia, S., Ansarin, K., Baradaran, B., Ahmadzadeh, V., & Safari, F. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.28357 · Cited by 19
Ju, Z.-R., Su, M., Li, D.-D., Hong, J., Im, D., Kim, S., Kim, E. L., & Jung, J. H. (2019) · Marine Drugs · doi:10.3390/md17060321 · Cited by 19
Ya, F.-L., Li, Q., Wang, D.-L., Xie, S.-F., Song, F., Gallant, R. C., Tian, Z., Wan, J.-B., Ling, W., & Yang, Y. (2018) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1656551 · Cited by 19
Trichomonas vaginalis Induces SiHa Cell Apoptosis by NF-κB Inactivation via Reactive Oxygen Species
Quan, J.-H., Kang, B.-H., Yang, J.-B., Rhee, Y., Noh, H., Choi, I.-W., Cha, G.-H., Yuk, J., & Lee, Y.-H. (2017) · BioMed Research International · doi:10.1155/2017/3904870 · Cited by 19
Hou, J.-J., Jiang, S., Zhao, J.-B., Zhu, D., Zhao, X., Cai, J.-C., & Zhang, S.-Q. (2017) · Scientific Reports · doi:10.1038/s41598-017-15074-5 · Cited by 19
Qu, T.-L., Wang, E., Jin, B., Li, W.-P., Liu, R.-L., & Zhao, Z.-B. (2017) · Immunopharmacology and immunotoxicology · doi:10.1080/08923973.2016.1274997 · Cited by 19
Tian, Y., Zhang, J., Jia, Z., Pan, X.-H., Hu, Z., Kang, R.-X., Zhou, X., Luo, L., Shen, Z.-Q., & Shen, Q. (2025) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2025.02.078 · Cited by 18
Kim, Y.-K., Cho, M., & Kang, D.-J. (2024) · Current Issues in Molecular Biology · doi:10.3390/cimb46060364 · Cited by 18
Affected inflammation-related signaling pathways in snake envenomation: A recent insight.
Luo, P., Ji, Y., Liu, X., Zhang, W., Cheng, R., Zhang, S., Qian, X., & Huang, C.-H. (2023) · Toxicon · doi:10.1016/j.toxicon.2023.107288 · Cited by 18
Yi, C., Liang, H.-L., Huang, D.-Y., Yu, H., Xue, C.-Y., Gu, J.-Z., Chen, X.-R., Wang, Y., Ren, M.-C., & Zhang, L. (2023) · Animals · doi:10.3390/ani13182980 · Cited by 18
Negi, A., Kesari, K. K., & Voisin‐Chiret, A. S. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14112523 · Cited by 18
“The peptidic character of IκBα limits its cellular penetrability and requires phosphorylation on two serine residues to be recognized by SCFβ−TRCP, making it susceptive to phosphatases [74].”
BackgroundModulation of Inflammation by Plant-Derived Nutraceuticals in Tendinitis
Mueller, A., Brockmueller, A., Kunnumakkara, A. B., & Shakibaei, M. (2022) · Nutrients · doi:10.3390/nu14102030 · Cited by 25
“Under resting conditions, NF-κB is located as a heterodimeric complex consisting of p50 and p65 in a latent state in the cytoplasm, bound to its natural inhibitor nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor alpha (IκBα) [83,84].”
BackgroundLeitner, P. D., Jakschitz, T., Gstir, R., Stuppner, S., Perkams, S., Kruus, M., Trockenbacher, A., Griesbeck, C., Bonn, G., Huber, L. A., et al. (2022) · Cells · doi:10.3390/cells11091407 · Cited by 18
The Kynurenine Pathway and Polycystic Ovary Syndrome: Inflammation as a Common Denominator
Jovanović, F., Sudhakar, A., & Knežević, N. N. (2022) · International Journal of Tryptophan Research · doi:10.1177/11786469221099214 · Cited by 23
Suzuki, T., Yamashita, S., Hattori, K., Matsuda, N., & Hattori, Y. (2021) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/s00210-021-02137-8 · Cited by 18
Jin, J., Zhou, M.-R., Wang, X., Liu, M., Huang, H.-L., Yan, F., Yu, Z., Shu, X.-H., Huo, X.-K., Feng, L., et al. (2020) · Fitoterapia · doi:10.1016/j.fitote.2020.104779 · Cited by 18
Niccolai, E., Boem, F., Emmi, G., & Amedei, A. (2020) · Immunology Letters · doi:10.1016/j.imlet.2020.03.001 · Cited by 23
Therapeutic Effects of Curcumin against Bladder Cancer: A Review of Possible Molecular Pathways.
Ashrafizadeh, M., Yaribeygi, H., & Sahebkar, A. (2020) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520620666200203143803 · Cited by 18
Bie, N., Han, L.-R., Meng, M., Zhang, Y., Guo, M.-Z., & Wang, C.-L. (2020) · doi:10.1016/j.jff.2019.103739 · Cited by 18
Shan, S., Liu, R.-R., Feng, H., Zhang, Y.-H., Zhang, F.-M., Lv, C., & Yang, G.-W. (2019) · Fish and Shellfish Immunology · doi:10.1016/j.fsi.2019.10.014 · Cited by 18
Simeone, K., Guay-Lord, R., Lateef, M. A., Péant, B., Kendall-Dupont, J., Orimoto, A., Carmona, E., Provencher, D., Saad, F., Gervais, T., et al. (2019) · Lab on a Chip · doi:10.1039/c8lc00982a · Cited by 18
Genome-wide DNA methylation patterns in coronary heart disease
Wang, X., Liu, A.-H., Jia, Z., Pu, K., Chen, K.-Y., & Guo, H. (2017) · Herz · doi:10.1007/s00059-017-4616-8 · Cited by 19
Effects of mycoplasma infection on the host organism response via p53/NF‐κB signaling
Borchsenius, S. N., Daks, A. A., Fedorova, O., Chernova, O. A., & Barlev, N. A. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26781 · Cited by 27
Yang, Y.-W., Wang, Y.-L., Lu, J.-K., Tian, L., Jin, M., & Cheng, W.-P. (2018) · Neural Regeneration Research · doi:10.4103/1673-5374.228757 · Cited by 18
“It is well known that necrosis and apoptosis can coexist in SCI (Karin and Ben-Neriah, 2000).”
BackgroundZhao, P., Guo, T.-T., Qian, L.-P., Wang, X.-F., Yuan, Y.-K., Cheng, Q., Zuo, Y.-B., Liu, J., Miao, Y., Feng, Q., et al. (2017) · Antiviral Research · doi:10.1016/j.antiviral.2017.06.002 · Cited by 18
“SCF TrCP E3 ligases can induce ubiquitination and degradation of phosphorylated substrates including (IkB) (Kanarek and Ben-Neriah, 2012; Karin and Ben-Neriah, 2000), b-catenin (Noubissi et al.”
BackgroundImmune defects caused by mutations in the ubiquitin system
Etzioni, A., Ciechanover, A. J., & Pikarsky, E. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.11.031 · Cited by 17
Ogada, P. A., Kiirika, L. M., Lorenz, C., Senkler, J., Braun, H., & Poehling, H. (2016) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2016.10.013 · Cited by 15
Kim, S.-L., Kim, S., Park, Y. R., Liu, Y.-C., Kim, E.-M., Jeong, H.-J., Kim, Y. N., Seo, S., Kim, I., Lee, S.-O., et al. (2016) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-16-0101 · Cited by 18
“IKK phosphorylates NF-kB–bound IkBs and targets them for ubiquitindependent degradation, allowing liberated NF-kB dimers to enter the nucleus (47).”
BackgroundXia, W., & Geng, K. (2016) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2016.07.020 · Cited by 19
Chen, H., Xu, Y., Qiu, J.-L., Guan, Z.-W., Yu, S.-P., & Ding, Y. (2026) · European Journal of Medical Research · doi:10.1186/s40001-025-03666-1 · Cited by 17
Zhang, L., Gao, Y., Zhou, H., Liang, X. H., Jiang, X., Gong, W., Sun, Y., Zhang, D., Wang, X., Nauwynck, H., et al. (2025) · PLoS Pathogens · doi:10.1371/journal.ppat.1012915 · Cited by 18
“Once the serine on the activation loop of IKK β is mutated to alanine, TNF-α , IL-1, and LPS all fail to activate NF-κ B [12].”
Jiang, C., Zhang, C., Dai, M., Wang, F., Xu, S., Han, D., Wang, Y., Cao, Y.-J., Liang, Y., Zhang, Z., et al. (2023) · Biochimica et biophysica acta. Molecular cell research · doi:10.1016/j.bbamcr.2023.119595 · Cited by 17
MiR-196b-5p activates NF-κB signaling in non-small cell lung cancer by directly targeting NFKBIA
Zhu, W., Yu, Y., Ye, Y., Tu, X., Zhang, Y., Wu, T., Ni, L., Huang, X., Wang, Y., & Cui, R. (2023) · Translational Oncology · doi:10.1016/j.tranon.2023.101755 · Cited by 16
“NFKBIA, also known as IκBα, is a member of IkBs that negatively regulates NF-κB signaling [15].”
BackgroundInfluentialShan, M., Meng, F.-Q., Tang, C., Zhou, L.-B., Lu, Z., & Lu, Y. (2021) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-021-11719-8 · Cited by 17
“When stimulated by inflammatory factors, IκBα will be phosphorylated and degraded, and two dimers of NF-κB will be released into the cell nucleus, and then NF-κB is activated (Karin and Ben-Neriah 2000).”
BackgroundTICAM-1/TRIF associates with Act1 and suppresses IL-17 receptor–mediated inflammatory responses
Miyashita, Y., Kouwaki, T., Tsukamoto, H., Okamoto, M., Nakamura, K., & Oshiumi, H. (2021) · Life Science Alliance · doi:10.26508/lsa.202101181 · Cited by 17
“…et al. https://doi.org/10.26508/lsa.202101181 vol 5 | no 2 | e202101181 4 of 14 TICAM-1 is a negative regulator of IL-17RA signaling Miyashita et al. https://doi.org/10.26508/lsa.202101181 vol 5 | no 2 | e202101181 5 of 14 is a hallmark of NF-κB pathway activation (Karin & Ben-Neriah, 2000).”
BackgroundInfluentialMoretti, I. F., Lerário, A., Trombetta-Lima, M., Sola, P., Soares, R. D. S., Oba-Shinjo, S., & Marie, S. K. N. (2021) · Scientific Reports · doi:10.1038/s41598-020-79356-1 · Cited by 17
Ubiquitination modification: critical regulation of IRF family stability and activity
Liu, B., Jin, J., & Li, Y. (2020) · Science China Life Sciences · doi:10.1007/s11427-020-1796-0 · Cited by 23
Chen, J.-X., Cheng, C.-S., Chen, J., Lv, L., Chen, Z.-X., Chen, C., & Zheng, L. (2020) · Evidence-Based Complementary and Alternative Medicine · doi:10.1155/2020/7259686 · Cited by 17
Suhail, M., Parveen, A., Husain, A., & Rehan, M. (2019) · Biosciences Biotechnology Research Asia · doi:10.13005/bbra/2787 · Cited by 17
Qin, F., Zhao, Y., Shang, W., Zhao, Z.-M., Qian, X., Zhang, B., & Cai, H. (2018) · Cellular and Molecular Biology · doi:10.14715/cmb/2018.64.10.23 · Cited by 17
“In the classic NF-κB pathway, various pathogens, including reactive oxygen species, endotoxin, bacterial tumor necrosis factor alpha, etc, are considered as common stimuli for incurable inflammation (14).”
BackgroundImportins α and β Signaling Mediates Endothelial Cell Inflammation and Barrier Disruption
Leonard, A., Rahman, A., & Fazal, F. (2018) · Cellular Signalling · doi:10.1016/j.cellsig.2018.01.011 · Cited by 17
Lu, C.-W., Lin, Y., Lei, Y., Wang, L., He, Z.-M., & Xiong, Y. (2017) · PLoS ONE · doi:10.1371/journal.pone.0179908 · Cited by 17
Regulation of NLRP3/TRIM family signaling in gut inflammation and colorectal cancer
Mohapatra, B. S., Lavudi, K., Kokkanti, R. R., & Patnaik, S. (2025) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2025.189271 · Cited by 16
Choi, W.-S., Kim, H. S., Kim, D., Hong, Y.-D., Kim, H.-J., Kim, J. H., Kim, J.-H., & Cho, J. Y. (2024) · Journal of Ginseng Research · doi:10.1016/j.jgr.2024.08.003 · Cited by 16
Nimbolide Targets Multiple Signalling Pathways to Reduce Neuroinflammation in BV-2 Microglia
Katola, F. O., & Olajide, O. A. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03410-y · Cited by 16
Li, Z., Zhao, M., Zhang, X., Lu, Y., Yang, Y., Xie, Y., Zou, Z., Zhou, L., Shang, R., Zhang, L., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1080438 · Cited by 17
“IκB kinases (IKKs) act immediately after TLR4/MyD88 signaling to phosphorylate IκB and NF-κB p65, which results in the degradation of IκB and nuclear translocation of NF-κB p65 (Karin and Ben-Neriah, 2000).”
BackgroundWang, C., Qu, R., Zong, Y., Qin, C., Liu, L., Gao, X., Sun, H., Sun, Y., Chang, K., Zhang, R., et al. (2022) · PLoS Pathogens · doi:10.1371/journal.ppat.1010645 · Cited by 16
“A typical example is the phosphorylation of IκB at S32 and S36 by IκB kinase, which is the signal for ubiquitination and degradation by the proteasome [25].”
BackgroundKiddane, A. T., Kang, M.-J., Ho, T., Getachew, A., Patil, M., Chun, B.-S., & Kim, G.-D. (2022) · Current Issues in Molecular Biology · doi:10.3390/cimb44030067 · Cited by 16
“IκB is rapidly phosphorylated, ubiquitinated, and degraded by the proteasome, and the released NFκB dimer is then transferred to the nucleus, where it can regulate specific gene expression [24].”
BackgroundMAP3K7-IKK Inflammatory Signaling Modulates AR Protein Degradation and Prostate Cancer Progression
Huang, Z., Tang, B., Yang, Y., Yang, Z., Shi, L., Bai, Y., Yan, B., Karnes, R. J., Zhang, J., Jiménez, R. E., et al. (2021) · Cancer Research · doi:10.1158/0008-5472.can-20-4194 · Cited by 24
“Increasing evidence indicates that IKK phosphorylation sequences often serve as the phosphodegrons recognized by b-TRCP (39, 40).”
BackgroundHost Innate Immune Response and Viral Immune Evasion During Alphaherpesvirus Infection
Lum, K. K., & Cristea, I. M. (2020) · Caister Academic Press eBooks · doi:10.21775/9781913652555.07 · Cited by 6
“Relevant to active innate immune signal transduction, cells require the proteasomal degradation of IκB to release the inhibition of NF-κB and promote its translocation into the nucleus (Karin and Ben-Neriah, 2000).”
BackgroundChoe, S.-H., Choi, E., Hyeon, J.-Y., Keum, B. R., Choi, I. S., & Kim, S. (2020) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-020-01958-3 · Cited by 16
Ma, X.-Y., Ma, T.-C., Feng, Y.-F., Xiang, G., Lei, W., Zhou, D.-P., Yu, H.-L., Xiang, L., & Wang, L. (2020) · Biomedical Materials · doi:10.1088/1748-605x/abaaa1 · Cited by 16
“NF-κ Bp65 then entered into the nucleus, enhancing the transcription of target genes containing pro-inflammatory cytokines, chemokines, and cell-survival genes [34, 48].”
Hartman, M. L., Rogut, M., Mielczarek-Lewandowska, A., Woźniak, M., & Czyż, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21113749 · Cited by 16
“In addition, phosphorylation of p65 at Ser 536 is managed in the cytoplasm by a plethora of kinases such as TANK-binding kinase 1 (TBK1), ribosomal kinase 1 (RSK1) and AKT1, in addition to IKK [70–72].”
MSIT: Malonylation Sites Identification Tree
Bao, W., Huang, D.-S., & Chen, Y. (2020) · Current Bioinformatics · doi:10.2174/1574893614666190730110747 · Cited by 19
Piccoli, B., Segatto, A., Oliveira, C., da Silva, F. D., Aschner, M., & da Rocha, J. B. T. (2019) · BMC Pharmacology and Toxicology · doi:10.1186/s40360-019-0356-0 · Cited by 16
Wang, R., Peng, S., Zhang, X., Wu, Z., Duan, H., Yuan, Y., & Wang, W. (2018) · International Journal of Cancer · doi:10.1002/ijc.31907 · Cited by 17
Wang, D., Jiang, Y.-L., Yang, X.-X., Wei, Q., & Wang, H.-M. (2018) · Korean Journal of Physiology and Pharmacology · doi:10.4196/kjpp.2018.22.6.627 · Cited by 16
“Upon activation, NF- Bp65 migrates to the nucleus, eventually leading to the expression and release of several pro-inflammatory cytokines [45-47].”
BackgroundTanaka, Y., Sabharwal, L., Ota, M., Nakagawa, I., Jiang, J., Arima, Y., Ogura, H., Okochi, M., Ishii, M., Kamimura, D., et al. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1701446 · Cited by 22
ARD1 contributes to IKKβ-mediated breast cancer tumorigenesis
Zhang, Y., Zhou, H., Tao, Y., Liu, X., Yuan, Z., & Nie, C.-L. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0921-2 · Cited by 16
Dysfunction of cholesterol sensor SCAP promotes inflammation activation in THP-1 macrophages
Ouyang, N., Gan, H., He, Q., Lei, H., Wang, S. Y., Liu, Q., & Zhou, C. (2018) · Experimental Cell Research · doi:10.1016/j.yexcr.2018.03.032 · Cited by 14
Matsumoto, K., Kose, S., Kuwahara, I., Yoshimura, M., Imamoto, N., & Yoshida, M. (2018) · Scientific Reports · doi:10.1038/s41598-018-24401-3 · Cited by 16
Perez, J. M., Chen, Y., Xiao, T. S., & Abbott, D. W. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.ra117.000408 · Cited by 20
Fung, G., Wong, J., Berhe, F., Mohamud, Y., Xue, Y., & Luo, H.-L. (2017) · OncoTarget · doi:10.18632/oncotarget.20366 · Cited by 16
“Phosphorylation of some proteins, such as IκBα, has been shown to be required for ubiquitin ligase recognition and consequent substrate ubiquitination and proteasome degradation [32].”
BackgroundPost-translational modifications and their applications in eye research
Chen, B.-J., Lam, T. C., Liu, L., & To, C. H. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.6529 · Cited by 19
“Abnormalities in the ubiquitin system have been associated with a number of pathogeneses, including neurodegenerative disorders (96,97), malignancies (98,99) and immunological disorders (100,101).”
Chicoric acid suppresses BAFF expression in B lymphocytes by inhibiting NF‐&kgr;B activity
Chen, L.-X., Huang, G., Gao, M., Shen, X.-D., Gong, W., Xu, Z., Zeng, Y.-J., & He, F. (2017) · International Immunopharmacology · doi:10.1016/j.intimp.2017.01.021 · Cited by 16
“In the canonical NF-κB signaling pathway, the IκBα kinase (IKK) complex promotes phosphorylation of the IκBα, leading to release and translocation of the p50-p65 heterodimer from the cytoplasm to the nucleus [22].”
BackgroundKuo, Y.-Z., Fang, W., Huang, C.-C., Tsai, S.-T., Wang, Y.-C., Yang, C.-L., & Wu, L.-W. (2017) · OncoTarget · doi:10.18632/oncotarget.14697 · Cited by 16
“Consistent with the inducing role of TNF-α on canonical NF-κB activation [34], TNF-α induced activating phosphorylation of NF-κB-p65 at S536 and destabling phosphorylation of IκBα at S32, leading to NF-κB activation, with a maximal induction at 10-50 ng/mL (Figure 8A, Right).”
BackgroundMao, Y., Su, C., Yang, H., Ma, X., Zhao, F., Qu, B., Yang, Y., Hou, X.-M., Zhao, B., & Cui, Y.-J. (2024) · Animal Biotechnology · doi:10.1080/10495398.2024.2314100 · Cited by 15
Hao, W., Yu, T., Zuo, D.-Z., Hu, H.-Z., & Zhou, P.-P. (2023) · Experimental Lung Research · doi:10.1080/01902148.2023.2286465 · Cited by 18
Metadata
- Authors
- Karin, M., & Ben-Neriah, Y.
- Affiliations
- Hebrew University of Jerusalem (IL)
- Department of Pharmacology, Laboratory of Gene Regulation and Signal Transduction University of California, San Diego, La Jolla, California, 92093-0636;
- ORCID
- Karin, Michael
- Venue
- Annual Review of Immunology
- Publisher
- Annual Reviews
- Published
- 2000-04
- Volume
- 18
- Issue
- 1
- Pages
- 621-663
- ISSN
- 0732-0582 (ISSN-L)
- 1545-3278
- OpenAlex
- W2147921405
- Cited by
- 4,766
- References
- 243
- Citations by year
- 2026: 78 · 2025: 109 · 2024: 86 · 2023: 101 · 2022: 114 · 2021: 112 · 2020: 129 · 2019: 114 · 2018: 129 · 2017: 153 · 2016: 156 · 2015: 135 · 2014: 186 · 2013: 201 · 2012: 194
- FWCI
- 22.12
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Annual Review of Immunology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (R01 CA76188, R01CA076188)
- National Institute of Allergy and Infectious Diseases (R01AI043477, R01 AI43477)
- National Institute of Environmental Health Sciences (R37ES004151, R37 ES04151)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Keywords
- NF-κB, IκB phosphorylation, ubiquitination, IκB kinase, IKKα, IKKβ, E3 ubiquitin ligase, proteolysis, NF-κB nuclear translocation, TNF signaling, IL-1 signaling, Rel family transcription factors, inflammation, transcriptional regulation
- MeSH terms
- NF-KappaB Inhibitor alpha, Amino Acid Sequence, Animals, DNA-Binding Proteins, Humans, Molecular Sequence Data, Phosphorylation, Transcription Factors, Ubiquitins, Signal Transduction, Down-Regulation, NF-kappa B, Protein Serine-Threonine Kinases, I-kappa B Proteins, I-kappa B Kinase, NF-kappa B p50 Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review